Terms of Reference, Membership and Report ISCB36 Utrecht 2015: AGM Wed 26 Aug ISCB Sub-Committee Statistics in Regulatory Affairs.

Slides:

Advertisements

Similar presentations

IEEE EAB Section Outreach Committee Update & Outcomes Anu Gokhale, SEOC Chair IEEE EAB BoD Meeting - 16 June 2007.

Advertisements

ASTM OFFICERS CONFERENCE SUBCOMMITTEE CHAIRMENS DUTIES AND RESPONSIBILITIES.

MAIN COMMITTEE OFFICERS DUTIES AND RESPONSIBILITIES.

MAIN COMMITTEE OFFICERS DUTIES AND RESPONSIBILITIES.

1 Accredited Standards Committee C63 ® - EMC Subcommittee 8 Bob DeLisi / Stephen Berger Chair / Vice-Chair

Terms of Reference, Membership and Report ISCB35 Vienna 2014: AGM Wed 27 Aug ISCB Sub-Committee Education.

Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.

DEPS Effects Committee Kick-off Mr Mark Neice, OSD/JTO Col David Robie, AF/A5RC Jim Rothenflue, LMCO 14 Oct 2009.

GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.

1 FDA DRAFT GUIDANCE ON CLINICAL TRIAL DATA MONTORING COMMITTEES Susan S. Ellenberg, Ph.D. Office of Biostatistics and Epidemiology Center for Biologics.

Proposal for a Constitution for MICE A Plan for Discussion P Dornan G Gregoire Y Nagashima A Sessler.

Terms of Reference, Membership and Report ISCB35 Vienna 2014: AGM Wed 27 Aug ISCB Sub-Committee SCA.

1 Accredited Standards Committee C63 ® - EMC Subcommittee 8 Bob DeLisi Chair 2015 May 07.

Iowa Administrator of the. Executive President ( aka Affiliate Director ) Vice President ( aka Co-Affiliate Director ) Executive Committee Treasurer Secretary.

Good Clinical Practice GCP

Accredited Member of the Association of Clinical Research Professionals, USA Tips on clinical trials Maha Al-Farhan B.Sc, M.Phil., M.B.A., D.I.C.

Overview of ICH Procedures July 2015

1 Accredited Standards Committee C63 ® - EMC Subcommittee 8 Bob DeLisi Chair

ISCB-SC - Saraswathi.S Saraswathi S PhD Student Iowa State University Ames, Iowa, USA Chairperson: ISCB-SC-RSG.

Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.

Impact of E9 Addendum to Industry

1 Accredited Standards Committee C63 ® - EMC Subcommittee 8 Bob DeLisi Chair

1 Accredited Standards Committee C63 ® - EMC Subcommittee 8 Bob DeLisi Chair

Scalability. What organizational structure will help us achieve the key enablers while allowing us to grow and preserve our principles?

European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) July 2015.

Faculty Senate Standing Committees Draft Presented by Richard Sher Faculty Meeting Sept. 19, 2012.

1 Updates on Regulatory Requirements for Missing Data Ferran Torres, MD, PhD Hospital Clinic Barcelona Universitat Autònoma de Barcelona.

Faculty Senate Proposal Ad Hoc Committee on College Rules.

Terms of Reference, Membership and Report ISCB35 Vienna 2014: AGM Wed 27 Aug ISCB Sub-Committee Epidemiology.

Terms of Reference, Membership and Report ISCB36 Utrecht 2015: AGM Wed 26 Aug ISCB Sub-Committee Conference Organising.

1 International Society for CNS Clinical Trials and Methodology FDA Advisory Committee Meeting Proposed Requirement for Long-Term Data to Support Initial.

Partnering With Industry for Clinical Research Luke Lin, MD, and Ralf Schnall.

Terms of Reference, Membership and Report ISCB36 Utrecht 2015: AGM Wed 26 Aug ISCB Sub-Committee SCA.

Preparation for FDA Advisory Committee Meetings Robert M. Kirsch, RAC Vice President, Regulatory Affairs TolerRx Inc. Cambridge, MA.

Terms of Reference, Membership and Report ISCB36 Utrecht 2015: AGM Wed 26 Aug ISCB Sub-Committee Education.

Bioequivalence Criteria Research Plan Stella G. Machado, Ph.D. Office of Biostatistics and the Replicate Design Technical Committee Advisory Committee.

1 Accredited Standards Committee C63 ® - EMC Subcommittee 8 Bob DeLisi Chair 2015 November 11.

INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)

EXCEPTION FROM INFORMED CONSENT IN CPR DEVICE TRIALS: PROTECTION OF PATIENTS’ RIGHTS Circulatory System Devices Panel Meeting September 21, 2004 Elisa.

Department of Health and Human Services1 Update: October 2006 Public Meeting on Emergency Research Diane Maloney, J.D. Associate Director for Policy FDA.

1 EBP Strategic Committee KRPIA EBP Meeting: 8 th January, 2010 EBP Chair: Tom Keith-Roach (AstraZeneca) Jannie Oosthuizen (Lilly)

Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.

Course title: RESEARCH PLANNING AND REPORT WRITING Lecture 1 Introduction to postgraduate research.

GCP (GOOD CLINICAL PRACTISE)

© Copyright Neuromed Why Things Are The Way They Are.... Monitoring, Data Chain of Custody, CRFs and Other Mysteries Revealed Christopher C. Gallen, M.D.,

Statistics in Regulatory Affairs

A systematic review of selected journals

FDA’s IDE Decisions and Communications

Presented by Rob Hemmings

How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.

Administering Informed Consent Issues for Discussion

Modernization of ICH E8 Sholeh Ehdaivand, President and CEO

Good Clinical Practice

Student Conference Awards

Statistics in Regulatory Affairs

Conference Organising

Greetings from 1st EFSPI regulatory workshop

ISCB Sub-Committee Education Terms of Reference, Membership and Report

Conference Organising

Conference Organising

Statistics in Regulatory Affairs

Making Your IRBs and Clinical Investigators HIPAA-Ready

Steering Committee, Eurostat, Luxembourg, 4 February 2011

Speaking on Behalf of ASME

Early Career Biostatisticians

Student Conference Awards

ISCB Sub-Committee Epidemiology

Student Conference Awards

Statistics in Regulatory Affairs

Presentation transcript:

Terms of Reference, Membership and Report ISCB36 Utrecht 2015: AGM Wed 26 Aug ISCB Sub-Committee Statistics in Regulatory Affairs

2 InformationTerms of Reference Members Statistics in Regulatory Affairs googlegroups.com The subcommittee on Regulatory Affairs will review, comment upon and seek to influence the development of regulatory requirements, guidelines and other documents concerning the scientific aspects of data generation, collection, management, analysis, and reporting. In general, the subcommittee will seek out and handle all regulatory issues in the name of the Society with the approval of the President or in his/her absence, the Vice ‑ President. Chair: Harbajan Chadha-Boreham (CH)* Secretary: Nicole Close (USA)* Members: Ralf Bender (DE) Tim Friede (DE) Christoph Gerlinger (DE) Thomas Jaki (UK ) + Stanislav Katina (CZ) + Christos Nakas (GR) Martin Schumacher (DE) Jørgen Seldrup (FR) Juan Torres (ES, CH) + Chris Weir (UK) + * Position changed; + New members Resigned: Jen-Pei Liu (TW) Resigned : Lutz Edler (DE)

 SiRA is piloting a new process for reviewing and commenting on draft regulatory guidelines:  Expert Review Committee (ERC) of ISCB members (including SiRA, as appropriate), who use Google-Docs as an aid to reaching consensus.  ISCB members’ comments are elicited for consolidation by the ERC.  FDA Draft Guidance “Adaptive Designs for Medical Device Clinical Studies” was circulated by SiRA for review/comment to be conducted via the above-mentioned process.  SiRA circulated an ICH-E9 survey to ISCB members, which relates to an addendum on issues surrounding “estimands, missing data and sensitivity analyses in the design and analysis of clinical trials”.  SiRA investigated the feasibility of the academic community being involved through ISCB during drafting of the “Addendum for ICH E6: Guideline for Good Clinical Practice”. The idea was abandoned.  The ICH Expert Working Groups are restricted to delegates from regulatory authorities and industry.  SiRA will wait for the release of the draft ICH-E6 Addendum for comment. 3